NursingNotes
  • login
  • signup
  • Latest News
  • Clinical Updates
  • Professional
  • Education
  • Opinion
No Result
View All Result
NursingNotes
No Result
View All Result

Home > News > Research

Dexamethasone found to help the sickest COVID-19 patients

The drug is inexpensive, on the shelf, and can be used immediately to save lives worldwide.


16 June 2020
Dexamethasone

Shutterstock

The steroid was shown to reduce deaths by one-third in the sickest COVID-19 patients.

Dexamethasone, an inexpensive steroid, has been shown to reduce the mortality rate of the COVID-19 presenting with severe respiratory complications.



In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone.

A total of 2104 patients received dexamethasone 6mg once per day (either by mouth or by intravenous injection) for ten days and were compared with 4321 patients who did not receive the drug.

Dexamethasone was shown to reduce deaths by one-third in ventilated patients and by one fifth in other patients receiving oxygen only. However, no benefit was shown among those patients who did not require respiratory support.

Based on these results, 1 death would be prevented by the treatment of around 8 ventilated patients or around 25 patients requiring oxygen alone.


Peter Horby, Professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford, and one of the Chief Investigators for the trial, said, “Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result.

“The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients.

“Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.’

The UK Government’s Chief Scientific Adviser, Sir Patrick Vallance, added, “This is tremendous news today from the Recovery trial showing that dexamethasone is the first drug to reduce mortality from COVID-19. It is particularly exciting as this is an inexpensive widely available medicine.


“This is a ground-breaking development in our fight against the disease, and the speed at which researchers have progressed finding an effective treatment is truly remarkable.

“It shows the importance of doing high-quality clinical trials and basing decisions on the results of those trials.’



Popular

Patient face mask in GP

GP practices can now deregister patients for ‘unrealistic service demands’

2 June 2022

student nurse staff nurse

Student nurses ‘used and abused’ on placements

13 June 2022

RCN

Nursing staff demand immediate review of ‘not fit for purpose’ Agenda for Change pay and conditions

8 June 2022

Insight

Busy A&E waiting room

‘The NHS is having its worst winter ever – and the reasons run much deeper than COVID’

28 January 2022

Hospital curtain intensive care

‘During the Downing Street Christmas Party we were caring for dying patients and forbidden from seeing family’

8 December 2021

Vaccine inPPE

‘Making vaccination compulsory for NHS frontline workers likely to make patients suffer’

19 November 2021


Related Posts

Close-up the positive young nurse who is dialing medicine into the syringe indoors
Clinical

Hospitals reintroduce compulsory mask wearing for staff and patients

29 June 2022
London, England, UK, January 22nd 2022, Long covid symptoms sign on pharmacy shop window UK
Clinical

Tribunal rules long-Covid is a disability

21 June 2022
Nurse putting PPE in bin
News

Nurses may not have died if the Government purchased ‘decent’ PPE

15 June 2022
NursingNotes

© 2019 NursingNotes.co.uk

Navigate Site

  • Who are we?
  • Terms of Service
  • Privacy Policy
  • Contact Us
  • Agenda for Change Pay Scales

Follow Us

No Result
View All Result
  • Latest News
  • Clinical
  • Education
  • Health Politics
  • Opinion
  • Resources

© 2019 NursingNotes.co.uk